Skip to Main Content

Paper Details

Genetic risk, dysbiosis, and treatment stratification using host genome and gut microbiome in inflammatory bowel disease.
Clin Transl Gastroenterol
63
2018
CD, Crohn's disease, HLA, IBD, Inflammatory bowel diseases, UC, host genome, human, human leukocyte antigen, inflammatory bowel disease, patients, stool microbial metagenome, ulcerative colitis, whole genome
Author NameAffiliation
Weizhong LiHuman Longevity Inc.
Weizhong LiJ. Craig Venter Institute
Weizhong LiHuman Longevity Inc.
Weizhong LiJ. Craig Venter Institute
Ericka L AndersonHuman Longevity Inc.
Parambir S DulaiUniversity of California
Parambir S DulaiUniversity of California San Diego
William J SandbornUniversity of California
William J SandbornUniversity of California San Diego
Shibu YoosephHuman Longevity Inc.
J C VenterHuman Longevity Inc.
J C VenterJ. Craig Venter Institute
Karen E NelsonJ. Craig Venter Institute
John T ChangUniversity of California
John T ChangUniversity of California San Diego
John T ChangUniversity of California
John T ChangUniversity of California San Diego
Amalio TelentiJ. Craig Venter Institute
Amalio TelentiJ. Craig Venter Institute
Brigid S BolandUniversity of California
Brigid S BolandUniversity of California San Diego
Brigid S BolandUniversity of California
Brigid S BolandUniversity of California San Diego
  • 1 - 23

Datasets

Release 1.2